Identification of New Prognostic Factors of Pulmonary Hypertension

被引:44
作者
Miura, Yutaka [1 ]
Fukumoto, Yoshihiro [1 ]
Sugimura, Koichiro [1 ]
Oikawa, Minako [1 ]
Nakano, Makoto [1 ]
Tatebe, Shunsuke [1 ]
Miyamichi, Saori [1 ]
Satoh, Kimio [1 ]
Shimokawa, Hiroaki [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
Cardiac index; Prognosis; Pulmonary hypertension; Thyroid dysfunction; RHO-KINASE INHIBITOR; ARTERIAL-HYPERTENSION; COMBINATION THERAPY; THYROID-DISEASE; EPOPROSTENOL; SILDENAFIL; BOSENTAN; HEMODYNAMICS; PROSTACYCLIN; MORTALITY;
D O I
10.1253/circj.CJ-10-0270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension (PH) still remains a serious disease, for which the plasma level of brain natriuretic peptide (BNP) and hemodynamic variables (eg, cardiac index Cl) are established prognostic factors The aim of the present study was to identify new additional prognostic factors of the disorder to improve the management of PH Methods and Results: The study cohort comprised 136 consecutive PH patients admitted to hospital from 1974 to 2008, all of whom were closely followed every 6-12 months During the follow-up period of 53 5 +/- 4 5 [SEM] months, 47 patients died of cardiopulmonary causes The patients who were initially treated with monotherapy showed improved pulmonary hemodynamics when subsequently treated with combination therapy Multivariate analysis showed that BNP and Cl were significant and independent prognostic factors in all PH patients. However, in PH patients with low Cl at diagnosis, only Cl improvement by PH therapy was a significant and independent prognostic factor Indeed, the patients with low CI at diagnosis (Cl <2 5) followed by subsequent normalization in response to therapy (Cl >= 2.5) showed a significantly better survival compared with those without such normalization Conclusions: Cl normalization in response to treatment is an independent new prognostic factor of PH in patients with low Cl at diagnosis, suggesting the importance of intensive therapy to achieve Cl normalization (Circ J 2010, 74: 1965-1971)
引用
收藏
页码:1965 / 1971
页数:7
相关论文
共 41 条
  • [21] Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension
    Machado, RD
    James, V
    Southwood, M
    Harrison, RE
    Atkinson, C
    Stewart, S
    Morrell, NW
    Trembath, RC
    Aldred, MA
    [J]. CIRCULATION, 2005, 111 (05) : 607 - 613
  • [22] Pulmonary arterial hypertension
    McLaughlin, Vallerie V.
    McGoon, Michael D.
    [J]. CIRCULATION, 2006, 114 (13) : 1417 - 1431
  • [23] ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
    McLaughlin, Vallerie V.
    Archer, Stephen L.
    Badesch, David B.
    Barst, Robyn J.
    Farber, Harrison W.
    Lindner, Jonathan R.
    Mathier, Michael A.
    McGoon, Michael D.
    Park, Myung H.
    Rosenson, Robert S.
    Rubin, Lewis J.
    Tapson, Victor F.
    Varga, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (17) : 1573 - 1619
  • [24] Nagaya N, 2000, CIRCULATION, V102, P865
  • [25] Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension
    Nagaya, N
    Uematsu, M
    Satoh, T
    Kyotani, S
    Sakamaki, F
    Nakanishi, N
    Yamagishi, M
    Kunieda, T
    Miyatake, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) : 487 - 492
  • [26] Pulmonary hypertension caused by Graves' thyrotoxicosis -: Normal pulmonary hemodynamics restored by 131I treatment
    Nakchbandi, IA
    Wirth, JA
    Inzucchi, SE
    [J]. CHEST, 1999, 116 (05) : 1483 - 1485
  • [27] Triiodothyronine levels for risk stratification of patients with chronic heart failure
    Pingitore, A
    Landi, P
    Taddei, MC
    Ripoli, A
    L'Abbate, A
    Iervasi, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 2005, 118 (02) : 132 - 136
  • [28] PRIMARY PULMONARY-HYPERTENSION - A NATIONAL PROSPECTIVE-STUDY
    RICH, S
    DANTZKER, DR
    AYRES, SM
    BERGOFSKY, EH
    BRUNDAGE, BH
    DETRE, KM
    FISHMAN, AP
    GOLDRING, RM
    GROVES, BM
    KOERNER, SK
    LEVY, PC
    REID, LM
    VREIM, CE
    WILLIAMS, GW
    [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) : 216 - 223
  • [29] Bosentan therapy for pulmonary arterial hypertension
    Rubin, LJ
    Badesch, DB
    Barst, RJ
    Galiè, N
    Black, CM
    Keogh, A
    Pulido, T
    Frost, A
    Roux, S
    Leconte, I
    Landzberg, M
    Simonneau, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) : 896 - 903
  • [30] TREATMENT OF PRIMARY PULMONARY-HYPERTENSION WITH CONTINUOUS INTRAVENOUS PROSTACYCLIN (EPOPROSTENOL) - RESULTS OF A RANDOMIZED TRIAL
    RUBIN, LJ
    MENDOZA, J
    HOOD, M
    MCGOON, M
    BARST, R
    WILLIAMS, WB
    DIEHL, JH
    CROW, J
    LONG, W
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (07) : 485 - 491